Highlight
The InEurHeart randomized controlled trial reveals that computed tomography (CT)-guided ventricular tachycardia (VT) ablation significantly reduces procedure time compared to conventional ablation approaches. It maintains comparable safety profiles and shows a substantial reduction in VT burden at one year, supporting CT integration as a promising tool in catheter ablation workflows for ischemic cardiomyopathy patients.
